Literature DB >> 16210794

Effects of long-term oral administration of ketoprofen in clinically healthy beagle dogs.

Tatsuya Narita1, Nobuyuki Tomizawa, Reeko Sato, Masanobu Goryo, Shigeo Hara.   

Abstract

To investigate the adverse effects of long-term administration of ketoprofen in dogs, ketoprofen (1 mg/kg) was administered to five clinically healthy beagle dogs (ketoprofen group) and gelatin capsules (control group) were administered to four clinically healthy beagle dogs for 30 days. We monitored the dogs through periodic physical examination, blood analyses, endoscopic examinations, fecal occult blood tests, renal function tests, urinalysis, urinary enzyme indices and cuticle bleeding time analysis. The lesions in the stomach, especially in the pyloric antrum, and fecal occult blood progressively worsened in the ketoprofen group. However, the differences between the ketoprofen group and the control group were not statistically significant. One dog in the ketoprofen group temporarily exhibited a decrease in renal plasma flow and two dogs exhibited enzymuria. However, these changes did not persist and the other examinations showed no significant difference between premedication and postmedication in the ketoprofen group. Therefore, the adverse effects of long-term administration of ketoprofen observed in this study were not clinically important in healthy dogs. Nevertheless, further investigation of adverse renal effects from long-term administration of ketoprofen is necessary in the dogs with subclinical renal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210794     DOI: 10.1292/jvms.67.847

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Diclofenac and ketoprofen liver toxicity in rat.

Authors:  Zdenko Tomic; Boris Milijasevic; Ana Sabo; Lalosevic Dusan; Vida Jakovljevic; Momir Mikov; Satman Majda; Velibor Vasovic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

2.  Pharmacokinetic Evaluation of a Novel Transdermal Ketoprofen Formulation in Healthy Dogs.

Authors:  Halley Gora Ravuri; Nana Satake; Alexandra Balmanno; Jazmine Skinner; Samantha Kempster; Paul C Mills
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.